Research & Clinical Trials
The Research Department at Premier Medical Group Urology Division has ongoing research trials at both our Poughkeepsie and Kingston locations. During the past 12 years our research department has conducted over 170 clinical trials for Premier Medical Group Urology Division. Premier Medical Group's Research Department has participated in clinical trials leading up to the approval of such drugs as Viagra, Levitra, Cialis, Detrol LA, Vesicare, Sanctura, Gelnique, Rapaflo, and Firmagon.
Dr. Evan Goldfischer serves as the Medical Director for the Research Department. He has published over 65 articles, abstracts, and newsletters for peer reviewed medical journals based on his experiences and research outcomes. Dr. Goldfischer has also presented nationally and internationally at scientific meetings based on his research findings.
The Research Department consists of a full-time clinical research manager and 4 full-time clinical research coordinators. The staff has over 25 years combined of clinical research experience, and all of our coordinators are ACRP certified.
Pharmaceutical research studies the effects of medications on certain symptoms or diseases. The research might involve medications that are already on the market, or those that are still in their study phase prior to release. Premier Medical Group Urology Division participates in research trials with a number of pharmaceutical companies testing medications in all stages of development, including Phase 1 - Phase IV. These studies include treatments for overactive bladder, benign prostatic hyperplasia (BPH), prostate cancer, bladder cancer, kidney cancer, erectile dysfunction, female sexual dysfunction, hypogonadism, and premature ejaculation.
Premier Medical Group Urology Division's clinical research program offers the opportunity for patients to receive the newest treatments in urology free of charge. In order to insure that the research patient's rights and safety are protected, all of the research protocols undergo review and approval from an Institutional Review Board. Each study is also approved by the Food and Drug Administration (FDA). All patients interested in participating in a clinical trial are required to sign an informed consent form, which details the nature of the study, the risks involved, and what may happen to a patient in the study. During the course of the study, Dr. Goldfischer and his staff are always available to answer any questions. Your privacy is protected, and your medical records are confidential.
The research department offers flexible scheduling and individualized attention to all our research participants. All study related procedures including lab work, physical exams, EKGs, and imaging studies are conducted at no cost, with most procedures done at our own offices. Most studies also offer research patients a small per visit stipend. Health insurance is not needed.
If you are interested in participating in a research study, please contact:
Jeanie Loeffell RN - Clinical Research Manager
Phone: 845-437-5000 Ext 1210
Email: research@premiermedicalhv.com